AKEBIA THERAPEUTIC revenue breakdown overview

AKEBIA THERAPEUTIC revenue for the last year amounted to 145.48 M CHF, the most of which — 145.48 M CHF — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 163.86 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought AKEBIA THERAPEUTIC 145.48 M CHF, and the year before that — 163.86 M CHF.